HAEHaemonetics Corporation
107.09USD-1.22%Mkt Cap: 4.93B $P/E: 52.37

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collectio…

Key Statistics

Company
Market Cap4.93B $
Enterprise Value5.87B $
Revenue (TTM)1.35B $
Gross Profit787.59M $
Net Income (TTM)97.31M $
Revenue/Share29.08 USD
Last Price107.09 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)52.37
P/E (Forward)18.85
PEG1.72
EV/EBITDA16.37
EV/Revenue4.34
P/S3.64
P/B5.88
EPS (TTM)2.07
EPS (Forward)5.74
52W Range
47.3298% of range108.50
52W High108.50 USD
52W Low47.32 USD
Profitability
Gross Margin59.04%
Oper. Margin17.93%
EBITDA Margin26.54%
Profit Margin7.29%
ROE12.22%
ROA4.06%
Growth
Revenue Growth5.60%
Earnings Growth2.90%
Cash Flow & Leverage
Operating CF293.22M $
CapEx (TTM)32.78M $
FCF Margin23.14%
FCF Yield6.34%
Net Debt949.64M $
Net Debt/EBITDA2.65
Balance Sheet
Debt/Equity1.54
Current Ratio3.08
Quick Ratio1.67
Book Value/Sh18.41 USD
Cash/Share4.935 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateDec 3, 2012
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)104.10 USD
Upside (mean)-2.8%
Target Range86.00 USD120.00 USD
$86.00-2.8% to mean$120.00
# Analysts10
Ownership
Shares Out.45.50M
Float44.89M
Insiders1.26%
Institutions112.60%
Short Interest
Short Ratio4.6d
Short % Float7.51%
Short % Out.6.42%
Shares Short2.92M
Short (prev mo.)2.91M
Technical
SMA 5081.25 (+31.8%)
SMA 20070.54 (+51.8%)
Beta0.52
S&P 52W Chg18.16%
Avg Vol (30d)592.01K
Avg Vol (10d)926.58K
Technical Indicators
RSI (14)84.7
MACD5.0278
MACD Signal3.6658
MACD Hist.+1.3620
BB Upper99.63 USD
BB Middle86.31 USD
BB Lower72.98 USD
BB Width30.87%
ATR (14)3.964 USD
Vol Ratio (20d)2.00x